- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Small Molecule Anti-tumor Targted Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Small Molecule Anti-tumor Targted Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Liver Cancer accounting for % of the Small Molecule Anti-tumor Targted Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While EGFR segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Small Molecule Anti-tumor Targted Drug include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, and Exelixis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Small Molecule Anti-tumor Targted Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
EGFR
ALK
Bcr-Abl
Others
Market segment by Application, can be divided into
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Market segment by players, this report covers
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Small Molecule Anti-tumor Targted Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Small Molecule Anti-tumor Targted Drug, with revenue, gross margin and global market share of Small Molecule Anti-tumor Targted Drug from 2019 to 2022.
Chapter 3, the Small Molecule Anti-tumor Targted Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Small Molecule Anti-tumor Targted Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Small Molecule Anti-tumor Targted Drug research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Small Molecule Anti-tumor Targted Drug
1.2 Classification of Small Molecule Anti-tumor Targted Drug by Type
1.2.1 Overview: Global Small Molecule Anti-tumor Targted Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type in 2021
1.2.3 EGFR
1.2.4 ALK
1.2.5 Bcr-Abl
1.2.6 Others
1.3 Global Small Molecule Anti-tumor Targted Drug Market by Application
1.3.1 Overview: Global Small Molecule Anti-tumor Targted Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Liver Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Gastric Cancer
1.3.6 Breast Cancer
1.3.7 Esophageal Cancer
1.3.8 Others
1.4 Global Small Molecule Anti-tumor Targted Drug Market Size & Forecast
1.5 Global Small Molecule Anti-tumor Targted Drug Market Size and Forecast by Region
1.5.1 Global Small Molecule Anti-tumor Targted Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Small Molecule Anti-tumor Targted Drug Market Size by Region, (2017-2022)
1.5.3 North America Small Molecule Anti-tumor Targted Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Small Molecule Anti-tumor Targted Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size and Prospect (2017-2028)
1.5.6 South America Small Molecule Anti-tumor Targted Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Small Molecule Anti-tumor Targted Drug Market Drivers
1.6.2 Small Molecule Anti-tumor Targted Drug Market Restraints
1.6.3 Small Molecule Anti-tumor Targted Drug Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Product and Solutions
2.1.4 Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Astrazeneca Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Small Molecule Anti-tumor Targted Drug Product and Solutions
2.2.4 Novartis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Millennium Pharmaceuticals
2.3.1 Millennium Pharmaceuticals Details
2.3.2 Millennium Pharmaceuticals Major Business
2.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product and Solutions
2.3.4 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Millennium Pharmaceuticals Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Small Molecule Anti-tumor Targted Drug Product and Solutions
2.4.4 Bayer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Exelixis
2.5.1 Exelixis Details
2.5.2 Exelixis Major Business
2.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Product and Solutions
2.5.4 Exelixis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Exelixis Recent Developments and Future Plans
2.6 Abbvie
2.6.1 Abbvie Details
2.6.2 Abbvie Major Business
2.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Product and Solutions
2.6.4 Abbvie Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Abbvie Recent Developments and Future Plans
2.7 Boehringer-Ingelheim
2.7.1 Boehringer-Ingelheim Details
2.7.2 Boehringer-Ingelheim Major Business
2.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product and Solutions
2.7.4 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Boehringer-Ingelheim Recent Developments and Future Plans
2.8 Eisai
2.8.1 Eisai Details
2.8.2 Eisai Major Business
2.8.3 Eisai Small Molecule Anti-tumor Targted Drug Product and Solutions
2.8.4 Eisai Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Eisai Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Product and Solutions
2.9.4 Pfizer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product and Solutions
2.10.4 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.11 Roche
2.11.1 Roche Details
2.11.2 Roche Major Business
2.11.3 Roche Small Molecule Anti-tumor Targted Drug Product and Solutions
2.11.4 Roche Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Roche Recent Developments and Future Plans
2.12 Bettapharma
2.12.1 Bettapharma Details
2.12.2 Bettapharma Major Business
2.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Product and Solutions
2.12.4 Bettapharma Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Bettapharma Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Small Molecule Anti-tumor Targted Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Small Molecule Anti-tumor Targted Drug Players Market Share in 2021
3.2.2 Top 10 Small Molecule Anti-tumor Targted Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Small Molecule Anti-tumor Targted Drug Players Head Office, Products and Services Provided
3.4 Small Molecule Anti-tumor Targted Drug Mergers & Acquisitions
3.5 Small Molecule Anti-tumor Targted Drug New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Small Molecule Anti-tumor Targted Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2017-2022)
5.2 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2028)
6.2 North America Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2028)
6.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Country
6.3.1 North America Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2028)
6.3.2 United States Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2028)
7.2 Europe Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2028)
7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country
7.3.1 Europe Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2028)
7.3.2 Germany Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
7.3.3 France Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region
8.3.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Region (2017-2028)
8.3.2 China Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
8.3.5 India Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2028)
9.2 South America Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2028)
9.3 South America Small Molecule Anti-tumor Targted Drug Market Size by Country
9.3.1 South America Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2028)
9.3.2 Brazil Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country
10.3.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2028)
10.3.2 Turkey Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Small Molecule Anti-tumor Targted Drug Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Small Molecule Anti-tumor Targted Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Small Molecule Anti-tumor Targted Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Small Molecule Anti-tumor Targted Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Small Molecule Anti-tumor Targted Drug Revenue (USD Million) by Region (2017-2022)
Table 5. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Region (2023-2028)
Table 6. Astrazeneca Corporate Information, Head Office, and Major Competitors
Table 7. Astrazeneca Major Business
Table 8. Astrazeneca Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 9. Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 13. Novartis Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Millennium Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 15. Millennium Pharmaceuticals Major Business
Table 16. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 17. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 21. Bayer Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Exelixis Corporate Information, Head Office, and Major Competitors
Table 23. Exelixis Major Business
Table 24. Exelixis Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 25. Exelixis Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Abbvie Corporate Information, Head Office, and Major Competitors
Table 27. Abbvie Major Business
Table 28. Abbvie Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 29. Abbvie Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Boehringer-Ingelheim Corporate Information, Head Office, and Major Competitors
Table 31. Boehringer-Ingelheim Major Business
Table 32. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 33. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Eisai Corporate Information, Head Office, and Major Competitors
Table 35. Eisai Major Business
Table 36. Eisai Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 37. Eisai Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 41. Pfizer Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 43. Bristol-Myers Squibb Major Business
Table 44. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 45. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Roche Corporate Information, Head Office, and Major Competitors
Table 47. Roche Major Business
Table 48. Roche Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 49. Roche Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Bettapharma Corporate Information, Head Office, and Major Competitors
Table 51. Bettapharma Major Business
Table 52. Bettapharma Small Molecule Anti-tumor Targted Drug Product and Solutions
Table 53. Bettapharma Small Molecule Anti-tumor Targted Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Small Molecule Anti-tumor Targted Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Small Molecule Anti-tumor Targted Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Small Molecule Anti-tumor Targted Drug Players Head Office, Products and Services Provided
Table 58. Small Molecule Anti-tumor Targted Drug Mergers & Acquisitions in the Past Five Years
Table 59. Small Molecule Anti-tumor Targted Drug New Entrants and Expansion Plans
Table 60. Global Small Molecule Anti-tumor Targted Drug Revenue (USD Million) by Type (2017-2022)
Table 61. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Type (2017-2022)
Table 62. Global Small Molecule Anti-tumor Targted Drug Revenue Forecast by Type (2023-2028)
Table 63. Global Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2022)
Table 64. Global Small Molecule Anti-tumor Targted Drug Revenue Forecast by Application (2023-2028)
Table 65. North America Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Small Molecule Anti-tumor Targted Drug Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Small Molecule Anti-tumor Targted Drug Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Small Molecule Anti-tumor Targted Drug Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Small Molecule Anti-tumor Targted Drug Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Small Molecule Anti-tumor Targted Drug Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Small Molecule Anti-tumor Targted Drug Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Small Molecule Anti-tumor Targted Drug Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Small Molecule Anti-tumor Targted Drug Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Small Molecule Anti-tumor Targted Drug Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Small Molecule Anti-tumor Targted Drug Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Small Molecule Anti-tumor Targted Drug Picture
Figure 2. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type in 2021
Figure 3. EGFR
Figure 4. ALK
Figure 5. Bcr-Abl
Figure 6. Others
Figure 7. Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application in 2021
Figure 8. Liver Cancer Picture
Figure 9. Colorectal Cancer Picture
Figure 10. Lung Cancer Picture
Figure 11. Gastric Cancer Picture
Figure 12. Breast Cancer Picture
Figure 13. Esophageal Cancer Picture
Figure 14. Others Picture
Figure 15. Global Small Molecule Anti-tumor Targted Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Small Molecule Anti-tumor Targted Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Region (2017-2028)
Figure 18. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Region in 2021
Figure 19. North America Small Molecule Anti-tumor Targted Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Small Molecule Anti-tumor Targted Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Small Molecule Anti-tumor Targted Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Small Molecule Anti-tumor Targted Drug Market Drivers
Figure 25. Small Molecule Anti-tumor Targted Drug Market Restraints
Figure 26. Small Molecule Anti-tumor Targted Drug Market Trends
Figure 27. Astrazeneca Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Millennium Pharmaceuticals Recent Developments and Future Plans
Figure 30. Bayer Recent Developments and Future Plans
Figure 31. Exelixis Recent Developments and Future Plans
Figure 32. Abbvie Recent Developments and Future Plans
Figure 33. Boehringer-Ingelheim Recent Developments and Future Plans
Figure 34. Eisai Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 37. Roche Recent Developments and Future Plans
Figure 38. Bettapharma Recent Developments and Future Plans
Figure 39. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Players in 2021
Figure 40. Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Small Molecule Anti-tumor Targted Drug Revenue Market Share in 2021
Figure 42. Global Top 10 Players Small Molecule Anti-tumor Targted Drug Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Type in 2021
Figure 45. Global Small Molecule Anti-tumor Targted Drug Market Share Forecast by Type (2023-2028)
Figure 46. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Application in 2021
Figure 47. Global Small Molecule Anti-tumor Targted Drug Market Share Forecast by Application (2023-2028)
Figure 48. North America Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2017-2028)
Figure 49. North America Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2017-2028)
Figure 50. North America Small Molecule Anti-tumor Targted Drug Revenue Market Share by Country (2017-2028)
Figure 51. United States Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2017-2028)
Figure 55. Europe Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2017-2028)
Figure 56. Europe Small Molecule Anti-tumor Targted Drug Revenue Market Share by Country (2017-2028)
Figure 57. Germany Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue Market Share by Region (2017-2028)
Figure 65. China Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2017-2028)
Figure 72. South America Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2017-2028)
Figure 73. South America Small Molecule Anti-tumor Targted Drug Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Small Molecule Anti-tumor Targted Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
